Serplulimab,Gastric Cancer, Adjuvant Therapy Clinical Trials in Shanghai

A Study to Evaluate Serplulimab in Combination With Docetaxel +S-1 VS. Docetaxel +S-1 as Adjuvant Treatment Therapy in Stage IIIc Gastric Cancer